What is he best known for?
The fields of study he is best known for:
Paul Dent focuses on Cancer research, Cell biology, Signal transduction, Kinase and MAPK/ERK pathway.
His Cancer research study combines topics in areas such as Cancer cell, Cancer, Apoptosis, Protein kinase B and Sodium butyrate.
His study looks at the relationship between Cell biology and fields such as Programmed cell death, as well as how they intersect with chemical problems.
He combines subjects such as Autocrine signalling and Cell growth with his study of Signal transduction.
His Kinase research includes elements of Molecular biology and Jurkat cells.
In his study, which falls under the umbrella issue of MAPK/ERK pathway, Epidermal growth factor receptor is strongly linked to Epidermal growth factor.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
- MAPK pathways in radiation responses (496 citations)
What are the main themes of his work throughout his whole career to date?
Paul Dent spends much of his time researching Cancer research, Apoptosis, Cell biology, Kinase and Molecular biology.
His Cancer research study combines topics from a wide range of disciplines, such as Protein kinase B, Cancer cell, Immunology, Programmed cell death and MAPK/ERK pathway.
Paul Dent has included themes like PI3K/AKT/mTOR pathway and Cell killing in his Protein kinase B study.
His Apoptosis research integrates issues from Leukemia, Protein kinase C, Prostate cancer and Downregulation and upregulation.
His study brings together the fields of Autophagy and Cell biology.
In his work, Virology is strongly intertwined with Cell culture, which is a subfield of Molecular biology.
He most often published in these fields:
- Cancer research (55.86%)
- Apoptosis (26.44%)
- Cell biology (24.85%)
What were the highlights of his more recent work (between 2014-2021)?
- Cancer research (55.86%)
- Autophagy (10.74%)
- PI3K/AKT/mTOR pathway (11.93%)
In recent papers he was focusing on the following fields of study:
Paul Dent mostly deals with Cancer research, Autophagy, PI3K/AKT/mTOR pathway, Pharmacology and Sorafenib.
His research in Cancer research tackles topics such as Afatinib which are related to areas like ErbB.
His Autophagy research is multidisciplinary, incorporating perspectives in Histone deacetylase, Immunotherapy and Cell biology.
His Protein kinase B research is multidisciplinary, incorporating elements of Histone deacetylase inhibitor and MAPK/ERK pathway.
His Autolysosome study incorporates themes from Chaperone-mediated autophagy and Computational biology.
His research in Apoptosis is mostly focused on Programmed cell death.
Between 2014 and 2021, his most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead (147 citations)
- HDAC inhibitors enhance the immunotherapy response of melanoma cells (61 citations)
In his most recent research, the most cited papers focused on:
Paul Dent spends much of his time researching Cancer research, Autophagy, PI3K/AKT/mTOR pathway, Pharmacology and Cell biology.
His Cancer research research includes themes of Afatinib and Immunotherapy.
His studies in Autophagy integrate themes in fields like Histone deacetylase and Programmed cell death.
His research integrates issues of BECN1, Autophagosome, Autolysosome, Chaperone-mediated autophagy and Computational biology in his study of Programmed cell death.
His PI3K/AKT/mTOR pathway research is multidisciplinary, incorporating perspectives in Hsp90, Protein kinase B and Cell killing.
As part of the same scientific family, Paul Dent usually focuses on Cell biology, concentrating on Cancer cell and intersecting with Intrinsic apoptosis, Null cell, Sphingosine and Contact inhibition.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
